Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions

Medicine and Dentistry

• Podocyte 100%
• Programmed Cell Death 50%
• Diabetes Mellitus 40%
• Oxime 40%
• Protein Expression 30%
• Glomerulus 30%
• Glucose 20%
• Hoe 33342 20%
• In Vitro 10%
• Pathogenesis 10%
• TUNEL Assay 10%
• Excretion 10%
• Caspase 3 10%
• Catenin 10%
• Albumin 10%
• Nephropathy 10%
• Streptozocin 10%
• Protein Bcl 2 10%
• Diabetic Nephropathy 10%
• Diluent 10%
• Therapeutic Procedure 10%
• Cells 10%
• Urinary System 10%

Biochemistry, Genetics and Molecular Biology

• Podocyte 100%
• Glycogen Synthase Kinase 3 60%
• Apoptosis 50%
• Rat 40%
• Protein Expression 30%
• Glucose 20%
• Staining 20%
• Molecule 10%
• Caspase 3 10%
• Catenin 10%
• Excretion 10%
• Bcl-2 10%
• Streptozotocin 10%
• TUNEL Assay 10%
• Mouse 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Western Blot 60%
• Glycogen Synthase Kinase 3 60%
• Diabetes Mellitus 40%
• Oxime 40%
• Rat 40%
• Glucose 20%
• Hoe 33342 20%
• Catenin 10%
• Caspase 3 10%
• Pathogenesis 10%
• Albumin 10%
• Kidney Disease 10%
• Diabetic Nephropathy 10%
• Diluent 10%
• Streptozotocin 10%
• Protein Bcl 2 10%
• Mouse 10%